JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Want to see JP:4552 full AI Analyst Report?
4552 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4552 Stock 12 Month Forecast
Average Price Target
¥900.00
▲(26.40% Upside)
| Highest Price Target¥900.00 | Average Price Target¥900.00 | Lowest Price Target¥900.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
¥900
Buy
26.40%
Upside
Upgraded
04/16/26
Citi
¥670
Hold
-5.90%
Downside
Reiterated
02/05/26
UBS
¥600
Hold
-15.73%
Downside
Reiterated
09/29/25
Nomura
¥520→¥660
Hold
-7.30%
Downside
Reiterated
07/31/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
¥900
Buy
26.40%
Upside
Upgraded
04/16/26
Citi
¥670
Hold
-5.90%
Downside
Reiterated
02/05/26
UBS
¥600
Hold
-15.73%
Downside
Reiterated
09/29/25
Nomura
¥520→¥660
Hold
-7.30%
Downside
Reiterated
07/31/25
Best Analysts Covering JCR Pharmaceuticals Co., Ltd.
3 Months
Success Rate
0/1 ratings generated profit
Average Return
-6.10%
Copying Miyabi Yamakita's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.10% per trade.
1 Year
Success Rate
0/1 ratings generated profit
Average Return
-6.10%
Copying Miyabi Yamakita's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.10% per trade.
2 Years
Success Rate
0/1 ratings generated profit
Average Return
-6.10%
Copying Miyabi Yamakita's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4552 Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
1
1
Buy
0
0
0
0
0
Hold
1
2
2
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
2
2
1
Each month's total comprises the sum of three months' worth of ratings.
4552 Financial Forecast
4552 Stock Forecast FAQ
What is JP:4552’s average 12-month price target, according to analysts?
Based on analyst ratings, JCR Pharmaceuticals Co., Ltd.’s 12-month average price target is 900.00.
What is JP:4552’s upside potential, based on the analysts’ average price target?
JCR Pharmaceuticals Co., Ltd. has 26.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JCR Pharmaceuticals Co., Ltd. a Buy, Sell or Hold?
JCR Pharmaceuticals Co., Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is JCR Pharmaceuticals Co., Ltd.’s share price target?
The average share price target for JCR Pharmaceuticals Co., Ltd. is 900.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ¥900.00 ,and the lowest forecast is ¥900.00. The average share price target represents 26.40% Increase from the current price of ¥712.
The highest analyst share price target is ¥900.00 ,and the lowest forecast is ¥900.00. The average share price target represents 26.40% Increase from the current price of ¥712.
What do analysts say about JCR Pharmaceuticals Co., Ltd.?
JCR Pharmaceuticals Co., Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of JCR Pharmaceuticals Co., Ltd.?
To buy shares of JP:4552, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.